MAPK3 and cancer: As demonstrated in Figure 1, cancer cell lines had constitutively phosphorylated ERK1/2; however, cisplatin resistant cells A2780cis and SK-OV-3 had 2.1- and 3.4-fold higher phosphorylation of ERK1/2 proteins than sensitive A2780 cells.